560 related articles for article (PubMed ID: 30261180)
21. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
[TBL] [Abstract][Full Text] [Related]
22. Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies.
Abe M; Goto T; Kennel SJ; Wolfenbarger D; Macy SD; Weiss DT; Solomon A
Am J Clin Pathol; 1993 Jul; 100(1):67-74. PubMed ID: 7688492
[TBL] [Abstract][Full Text] [Related]
23. Kappa and lambda light chain disease: survival rates and clinical manifestations.
Shustik C; Bergsagel DE; Pruzanski W
Blood; 1976 Jul; 48(1):41-51. PubMed ID: 820387
[TBL] [Abstract][Full Text] [Related]
24. In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis.
Klimtchuk ES; Prokaeva TB; Spencer BH; Gursky O; Connors LH
Amyloid; 2017 Jun; 24(2):115-122. PubMed ID: 28632419
[TBL] [Abstract][Full Text] [Related]
25. 'Transformation' from amyloid light chain amyloidosis to symptomatic multiple myeloma.
Rutten KHG; Raymakers RAP; Minnema MC
Neth J Med; 2018 Jul; 76(5):249-250. PubMed ID: 30019681
[TBL] [Abstract][Full Text] [Related]
26. The clinicopathological spectrum of renal amyloidosis.
Hsu JY; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):230-9. PubMed ID: 7982133
[TBL] [Abstract][Full Text] [Related]
27. Paraneoplastic cutaneous leukocytoclastic vasculitis disclosing multiple myeloma: a case report.
Peterlin P; Ponge T; Blin N; Moreau P; Hamidou M; Agard C
Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):373-4. PubMed ID: 21729687
[TBL] [Abstract][Full Text] [Related]
28. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
[TBL] [Abstract][Full Text] [Related]
29. AL amyloidosis is not present as an incidental finding in cutaneous biopsies of patients with multiple myeloma.
Bayer-Garner IB; Smoller BR
Clin Exp Dermatol; 2002 May; 27(3):240-2. PubMed ID: 12072017
[TBL] [Abstract][Full Text] [Related]
30. The Spectrum of Monoclonal Immunoglobulin-Associated Diseases.
Tuchman SA; Zonder JA
Hematol Oncol Clin North Am; 2020 Dec; 34(6):997-1008. PubMed ID: 33099435
[TBL] [Abstract][Full Text] [Related]
31. Mucocutaneous manifestations in systemic amyloidosis A retrospective analytical study in a tertiary care center.
Flores-Bozo LR; Echevarría-Keel J; Domínguez-Cherit J; Esquivel-Pedraza L; Méndez-Flores S
Int J Dermatol; 2019 Sep; 58(9):1062-1068. PubMed ID: 30941743
[TBL] [Abstract][Full Text] [Related]
32. Multiple myeloma and amyloidosis of the tongue.
Raubenheimer EJ; Dauth J; Pretorius FJ
J Oral Pathol; 1988 Nov; 17(9-10):554-9. PubMed ID: 3150443
[TBL] [Abstract][Full Text] [Related]
33. A 64-year-old woman with raccoon eyes following kidney biopsy: a case report.
Mei S; Zhao Y; Li L; Mei C; Dai B
BMC Nephrol; 2020 Apr; 21(1):140. PubMed ID: 32303194
[TBL] [Abstract][Full Text] [Related]
34. Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement.
Arnall JR; Usmani SZ; Adamu H; Mishkin J; Bhutani M
J Oncol Pharm Pract; 2019 Jun; 25(4):1021-1025. PubMed ID: 30477388
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies.
Montseny JJ; Kleinknecht D; Meyrier A; Vanhille P; Simon P; Pruna A; Eladari D
Nephrol Dial Transplant; 1998 Jun; 13(6):1438-45. PubMed ID: 9641173
[TBL] [Abstract][Full Text] [Related]
36. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic factors in light chain amyloidosis].
Jávorniczky NR; Bodó I; Masszi T; Mikala G
Orv Hetil; 2015 Sep; 156(39):1577-84. PubMed ID: 26550915
[TBL] [Abstract][Full Text] [Related]
38. Perianal purpuric plaques revealing an amyloid light-chain amyloidosis: case report and review of the literature.
Lopes S; Nogueira A; Gullo I; Pardal J; Lopes JM; Azevedo F
Dermatol Online J; 2019 Jan; 25(1):. PubMed ID: 30710905
[TBL] [Abstract][Full Text] [Related]
39. Metastatic cutaneous plasmacytoma: a case report associated with IgA lambda multiple myeloma and a review of the literature of metastatic cutaneous plasmacytomas associated with multiple myeloma and primary cutaneous plasmacytomas.
Kato N; Kimura K; Yasukawa K; Aikawa K
J Dermatol; 1999 Sep; 26(9):587-94. PubMed ID: 10535253
[TBL] [Abstract][Full Text] [Related]
40. [Bullous poikilodermatitic amyloidosis of the skin with junctional bulla development in IgG light chain plasmacytoma of the lambda type. Histology, immunohistology and electron microscopy].
Winzer M; Ruppert M; Baretton G; Quast U; Wolff HH
Hautarzt; 1992 Apr; 43(4):199-204. PubMed ID: 1597368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
